Mucosomal allergen-specific immunotherapy with initial...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/35 (2006.01) A61K 39/36 (2006.01)

Patent

CA 2720455

The present invention relates to mucosal allergen-specific immunotherapy with a seasonal allergen, wherein the therapy is initiated after start of the pollen season of the seasonal allergen. Preferably, the seasonal allergen is provided in solid dosage form and is administered daily. Furthermore, advantageously, the same dose may be used throughout the treatment period since up-dosing is not required.

La présente invention porte sur une immunothérapie spécifique d'un allergène mucosal avec un allergène de saison, la thérapie étant initiée après le début de la saison du pollen de l'allergène de saison. De préférence, l'allergène de saison est fourni sous forme posologique solide et être administré quotidiennement. De plus, de façon avantageuse, la même dose peut être utilisée pendant toute la période de traitement étant donné qu'un surdosage n'est pas requis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mucosomal allergen-specific immunotherapy with initial... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mucosomal allergen-specific immunotherapy with initial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucosomal allergen-specific immunotherapy with initial... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1564269

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.